Citation Impact
5 from Science/Nature 50 standout
Citing Papers
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Michail Doukas being referenced
Rintatolimod: a potential treatment in patients with pancreatic cancer expressing Toll-like receptor 3.
2023
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
2017
Author Peers
| Author | Surgery | Oncology | PRM | Immunology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Michail Doukas | 489 | 746 | 330 | 357 | 103 | 1.5k | |
| J. Haimson | 1 | 5 | 1 | 35 | 205 | ||
| I.H. Ayhan | 17 | 33 | 21 | 4 | 24 | 553 | |
| Virginia C. Crandall | 1 | 20 | 1.7k | ||||
| Andrew Hatch | 6 | 1 | 2 | 6 | 562 | ||
| Ellen A. Murray | 4 | 2 | 9 | 263 |
All Works
Login with ORCID to disown or claim papers
Loading papers...